MedTrace Logo

Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

NCT00822692 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2015-12-21

Study results available
· View outcomes & findings →

Summary

Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.

Conditions

  • Abscess
  • Methicillin-Resistant Staphylococcus Aureus Infection

Interventions

DRUG

Trim/ Sulfa DS

bactrim DS (800/160) two tablets PO BID x 7 days

DRUG

placebo

matched placebo 2 pills PO BID x 7 days

Sponsors & Collaborators

  • U.S. Air Force Office of the Surgeon General

    collaborator FED

  • Emergency Medicine Foundation

    collaborator OTHER

  • 59th Medical Wing

    lead FED

Principal Investigators

  • Gillian R Schmitz · 59th Medical Wing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822692 on ClinicalTrials.gov